| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |